the clinical outcome of HMG, HP-HMG, u-FSH and MPA used for ovarian stimulation in normalovulatory women

the clinical outcome of HMG, HP-HMG, u-FSH and MPA used for ovarian stimulation in normalovulatory w

Status

Recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OPN-14005276

Enrollment

Unknown

Registered

2014-09-23

Start date

2014-09-24

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

2:HP-HMG and MPA

3:u-FSH and MPA

1:HMG and MPA

Eligibility

Age

22 Years to 39 Years

Inclusion criteria

Inclusion criteria: Infertility women, aged 25-40years, normal mentrual cycle (23-35days), tubal or male factors, basal FSH less than 10IU/l, antral follicle counts more than 5.

Exclusion criteria

Exclusion criteria: PCOS, endometrosis grade 3 or higher, documented ovarian failure, and any contraindications to ovarian stimulation treatment.

Design outcomes

Primary

Measure	Time frame
number of oocyte retrieval;number of mature oocytes;number of fertilized oocytes;number of viable embryos;LH surge;the number of cleavaged embryos;	—

Countries

China

Contacts

Public ContactYanping Kuang

kuangyanp@126.com+86 21 53078108

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026